Numerous recent studies have indicated that TYK2 acts as an oncogene and promotes the migration, invasion, and metastasis of various cancers, including gastric, liver, colon, prostate, and lung cancers (Borcherding et al., 2021). This evidence concerns the gene TYK2 and cancer.